Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Ironwood Pharmaceuticals Total Long-Term Assets 2010-2025 | IRWD

Ironwood Pharmaceuticals total long-term assets from 2010 to 2025. Total long-term assets can be defined as the sum of all assets classified as non-current
  
Ironwood Pharmaceuticals Annual Total Long-Term Assets
(Millions of US $)
2024 $169
2023 $238
2022 $320
2021 $382
2020 $63
2019 $96
2018 $66
2017 $294
2016 $330
2015 $119
2014 $41
2013 $50
2012 $45
2011 $41
2010 $42
2009 $31
Ironwood Pharmaceuticals Quarterly Total Long-Term Assets
(Millions of US $)
2025-03-31 $167
2024-12-31 $169
2024-09-30 $211
2024-06-30 $217
2024-03-31 $231
2023-12-31 $238
2023-09-30 $270
2023-06-30 $286
2023-03-31 $289
2022-12-31 $320
2022-09-30 $341
2022-06-30 $358
2022-03-31 $373
2021-12-31 $382
2021-09-30 $384
2021-06-30 $387
2021-03-31 $61
2020-12-31 $63
2020-09-30 $59
2020-06-30 $69
2020-03-31 $70
2019-12-31 $96
2019-09-30 $77
2019-06-30 $95
2019-03-31 $162
2018-12-31 $66
2018-09-30 $168
2018-06-30 $339
2018-03-31 $295
2017-12-31 $294
2017-09-30 $311
2017-06-30 $364
2017-03-31 $343
2016-12-31 $330
2016-09-30 $349
2016-06-30 $314
2016-03-31 $108
2015-12-31 $119
2015-09-30 $108
2015-06-30 $127
2015-03-31 $42
2014-12-31 $41
2014-09-30 $42
2014-06-30 $45
2014-03-31 $48
2013-12-31 $50
2013-09-30 $50
2013-06-30 $48
2013-03-31 $49
2012-12-31 $45
2012-09-30 $44
2012-06-30 $43
2012-03-31 $43
2011-12-31 $41
2011-09-30 $41
2011-06-30 $41
2011-03-31 $43
2010-12-31 $42
2010-09-30 $41
2010-06-30 $40
2010-03-31 $32
2009-12-31 $31
2009-09-30 $32
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.126B $0.351B
Ironwood Pharmaceuticals, Inc. focuses on the development and commercialization of treatments primarily addressing gastrointestinal diseases. Linzess was launched in collaboration with Allergan for patients suffering from irritable bowel syndrome (IBS-C; 290 mcg) with constipation or chronic idiopathic constipation. Ironwood and AbbVie co-develop & co-commercialize Linzess in all other territories world wide. Linzess is marketed by Allergan for IBS-C in Europe and Canada under the brand name Constella. The company receives royalties on sales of Constella in Europe and Canada from AbbVie. In Japan, it has partnered with Astellas Pharma for the development and commercialization of Linzess and with AstraZeneca in China, Hong Kong & Macau. Linzess received approval for IBS-C indication in Japan for chronic constipation and in China for IBS-C. The company completed the spin-off of its soluble guanylate cyclase segment into a separate, publicly traded company, Cyclerion Therapeutics.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $86.521B 32.46
Zoetis (ZTS) United States $69.359B 25.88
Takeda Pharmaceutical (TAK) Japan $47.920B 9.53
Daiichi Sankyo, - (DSNKY) Japan $43.494B 22.29
BeOne Medicines - (ONC) Cayman Islands $27.892B 0.00
Sandoz Group AG (SDZNY) Switzerland $23.619B 0.00
Merck (MKKGY) Germany $16.901B 12.38
Summit Therapeutics (SMMT) United States $15.834B 0.00
Shionogi (SGIOY) Japan $14.955B 14.98
United Therapeutics (UTHR) United States $12.814B 11.34
Neurocrine Biosciences (NBIX) United States $12.540B 42.95
Orion OYJ (ORINY) Finland $10.495B 28.38
IPSEN (IPSEY) France $9.739B 0.00
Corcept Therapeutics (CORT) United States $7.882B 64.08
Stevanato Group S.p.A (STVN) Italy $7.598B 46.46
Madrigal Pharmaceuticals (MDGL) United States $6.650B 0.00
Ionis Pharmaceuticals (IONS) United States $6.331B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Grifols, S.A (GRFS) Spain $6.037B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.382B 13.33
Soleno Therapeutics (SLNO) United States $4.234B 0.00
Hypermarcas (HYPMY) Brazil $2.914B 19.17
Crinetics Pharmaceuticals (CRNX) United States $2.808B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.670B 9.35
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.548B 13.78
NewAmsterdam Pharma (NAMS) Netherlands $2.071B 0.00
BioCryst Pharmaceuticals (BCRX) United States $2.021B 0.00
Indivior (INDV) United States $1.888B 8.01
ARS Pharmaceuticals (SPRY) United States $1.776B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.742B 0.00
Endo (NDOI) United States $1.603B 0.00
Ocular Therapeutix (OCUL) United States $1.507B 0.00
Evotec AG (EVO) Germany $1.499B 0.00
Guardian Pharmacy Services (GRDN) United States $1.339B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.166B 23.32
Harrow (HROW) United States $1.150B 0.00
Dyne Therapeutics (DYN) United States $1.142B 0.00
Enliven Therapeutics (ELVN) United States $1.056B 0.00
Verve Therapeutics (VERV) United States $1.003B 0.00
Akebia Therapeutics (AKBA) United States $0.982B 0.00
Collegium Pharmaceutical (COLL) United States $0.961B 5.18
Avadel Pharmaceuticals (AVDL) Ireland $0.899B 0.00
Ardelyx (ARDX) United States $0.882B 0.00
Elite Pharmaceuticals (ELTP) United States $0.780B 0.00
Xeris Biopharma Holdings (XERS) United States $0.741B 0.00
Cronos Group (CRON) Canada $0.737B 0.00
Xencor (XNCR) United States $0.598B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.579B 0.00
USANA Health Sciences (USNA) United States $0.575B 12.50
KalVista Pharmaceuticals (KALV) United States $0.572B 0.00
Relay Therapeutics (RLAY) United States $0.569B 0.00
AleAnna (ANNA) United States $0.550B 0.00
Bioventus (BVS) United States $0.547B 13.88
Theravance Biopharma (TBPH) United States $0.537B 0.00
Zevra Therapeutics (ZVRA) United States $0.507B 0.00
Siga Technologies (SIGA) United States $0.469B 9.79
Organogenesis (ORGO) United States $0.458B 0.00
Oruka Therapeutics (ORKA) United States $0.435B 0.00
Liminatus Pharma (LIMN) United States $0.432B 0.00
Tourmaline Bio (TRML) United States $0.429B 0.00
Savara (SVRA) United States $0.382B 0.00
Nektar Therapeutics (NKTR) United States $0.368B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.335B 9.06
Heron Therapeutics (HRTX) United States $0.330B 0.00
Aquestive Therapeutics (AQST) United States $0.323B 0.00
Altimmune (ALT) United States $0.293B 0.00
Nature's Sunshine Products (NATR) United States $0.263B 24.19
Tonix Pharmaceuticals Holding (TNXP) United States $0.261B 0.00
Aldeyra Therapeutics (ALDX) United States $0.232B 0.00
Nanobiotix S.A (NBTX) France $0.223B 0.00
ProKidney (PROK) United States $0.212B 0.00
MediWound (MDWD) Israel $0.210B 0.00
OmniAb (OABI) United States $0.206B 0.00
Esperion Therapeutics (ESPR) United States $0.202B 0.00
Larimar Therapeutics (LRMR) United States $0.197B 0.00
4D Molecular Therapeutics (FDMT) United States $0.189B 0.00
Profound Medical (PROF) Canada $0.185B 0.00
Aclaris Therapeutics (ACRS) United States $0.169B 0.00
Innate Pharma SA (IPHYF) France $0.163B 0.00
Journey Medical (DERM) United States $0.163B 0.00
Galectin Therapeutics (GALT) United States $0.149B 0.00
Lexeo Therapeutics (LXEO) United States $0.139B 0.00
Avita Medical (RCEL) United States $0.135B 0.00
Lyell Immunopharma (LYEL) United States $0.135B 0.00
Inhibikase Therapeutics (IKT) United States $0.123B 0.00
Achieve Life Sciences (ACHV) Canada $0.122B 0.00
VAXART, INC (VXRT) United States $0.122B 0.00
Cardiol Therapeutics (CRDL) Canada $0.122B 0.00
Korro Bio (KRRO) United States $0.116B 0.00
Protara Therapeutics (TARA) United States $0.115B 0.00
Champions Oncology (CSBR) United States $0.100B 16.41
Corbus Pharmaceuticals Holdings (CRBP) United States $0.098B 0.00
Arch Biopartners (ACHFF) Canada $0.091B 0.00
Cassava Sciences (SAVA) United States $0.088B 0.00
Nutriband (NTRB) United States $0.087B 0.00
Dominari Holdings (DOMH) United States $0.086B 0.00
Fractyl Health (GUTS) United States $0.085B 0.00
Wellgistics Health (WGRX) United States $0.080B 0.00
Vivani Medical (VANI) United States $0.078B 0.00
ESSA Pharma (EPIX) Canada $0.077B 0.00
Unicycive Therapeutics (UNCY) United States $0.075B 0.00
Pyxis Oncology (PYXS) United States $0.073B 0.00
Surrozen (SRZN) United States $0.072B 0.00
Inotiv (NOTV) United States $0.063B 0.00
Assertio Holdings (ASRT) United States $0.062B 0.00
NRx Pharmaceuticals (NRXP) United States $0.061B 0.00
Gain Therapeutics (GANX) United States $0.060B 0.00
Metagenomi (MGX) United States $0.059B 0.00
Rafael Holdings (RFL) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Context Therapeutics (CNTX) United States $0.058B 0.00
PMV Pharmaceuticals (PMVP) United States $0.056B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.054B 0.00
Avalo Therapeutics (AVTX) United States $0.052B 0.00
Telomir Pharmaceuticals (TELO) United States $0.051B 0.00
Century Therapeutics (IPSC) United States $0.049B 0.00
Prelude Therapeutics (PRLD) United States $0.049B 0.00
Mural Oncology (MURA) Ireland $0.043B 0.00
Acrivon Therapeutics (ACRV) United States $0.041B 0.00
Iterum Therapeutics (ITRM) Ireland $0.041B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.040B 29.78
ElectroCore (ECOR) United States $0.040B 0.00
Karyopharm Therapeutics (KPTI) United States $0.039B 0.00
Klotho Neurosciences (KLTO) United States $0.037B 0.00
PolyPid (PYPD) Israel $0.036B 0.00
Jupiter Neurosciences (JUNS) United States $0.036B 0.00
SCYNEXIS (SCYX) United States $0.029B 0.00
Enlivex Therapeutics (ENLV) Israel $0.029B 0.00
China SXT Pharmaceuticals (SXTC) China $0.028B 0.00
Tempest Therapeutics (TPST) United States $0.026B 0.00
VYNE Therapeutics (VYNE) United States $0.025B 0.00
Relmada Therapeutics (RLMD) United States $0.022B 0.00
FibroGen (FGEN) United States $0.021B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
Vivos Therapeutics (VVOS) United States $0.020B 0.00
DURECT (DRRX) United States $0.019B 0.00
BioVie (BIVI) United States $0.019B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
Plus Therapeutics (PSTV) United States $0.019B 0.00
Mannatech (MTEX) United States $0.018B 0.00
Lyra Therapeutics (LYRA) United States $0.018B 0.00
Lipocine (LPCN) United States $0.017B 0.00
Carisma Therapeutics (CARM) United States $0.017B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.017B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.017B 0.00
CASI Pharmaceuticals (CASI) China $0.016B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
Citius Pharmaceuticals (CTXR) United States $0.014B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
Scienture Holdings (SCNX) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.013B 2.20
Cosmos Health (COSM) United States $0.013B 0.00
Crescent Biopharma (CBIO) United States $0.011B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
Ainos (AIMD) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Alaunos Therapeutics (TCRT) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
SHINECO (SISI) China $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00